Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results

• Takahiro Oike,

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Yoshiyuki Suzuki ,

  * E-mail: syoshi@med.gunma-u.ac.jp

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Ken-ichi Sugawara,

  Affiliation Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Katsuyuki Shirai,

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Shin-ei Noda,

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Tomoaki Tamaki,

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Masaya Nagaishi,

  Affiliation Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Hideaki Yokoo,

  Affiliation Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Yoichi Nakazato,

  Affiliation Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯
• Takashi Nakano

  Affiliation Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

  ⨯